These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29089771)

  • 1. A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness.
    Kopelowicz A; Baker RA; Zhao C; Brewer C; Lawson E; Peters-Strickland T
    Neuropsychiatr Dis Treat; 2017; 13():2641-2651. PubMed ID: 29089771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis.
    Fowler JC; Cope N; Knights J; Phiri P; Makin A; Peters-Strickland T; Rathod S
    BMJ Open; 2019 Jun; 9(6):e025952. PubMed ID: 31253613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole.
    Peters-Strickland T; Pestreich L; Hatch A; Rohatagi S; Baker RA; Docherty JP; Markovtsova L; Raja P; Weiden PJ; Walling DP
    Neuropsychiatr Dis Treat; 2016; 12():2587-2594. PubMed ID: 27785036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital Medicine System in Veterans With Severe Mental Illness: Feasibility and Acceptability Study.
    Gonzales S; Okusaga OO; Reuteman-Fowler JC; Oakes MM; Brown JN; Moore S; Lewinski AA; Rodriguez C; Moncayo N; Smith VA; Malone S; List J; Cho RY; Jeffreys AS; Bosworth HB
    JMIR Form Res; 2022 Dec; 6(12):e34893. PubMed ID: 36548028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis.
    Fowler JC; Cope N; Knights J; Fang H; Skubiak T; Shergill SS; Phiri P; Rathod S; Peters-Strickland T
    Neuropsychiatr Dis Treat; 2021; 17():483-492. PubMed ID: 33603385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.
    Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L
    J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance, Reliability, Usability, and Safety of the ID-Cap System for Ingestion Event Monitoring in Healthy Volunteers: A Pilot Study.
    Flores GP; Peace B; Carnes TC; Baumgartner SL; Buffkin DE; Euliano NR; Smith LN
    Innov Clin Neurosci; 2016; 13(9-10):12-19. PubMed ID: 27974996
    [No Abstract]   [Full Text] [Related]  

  • 8. Are caregivers ready for digital? Caregiver preferences for health technology tools to monitor medication adherence among patients with serious mental illness.
    Forma F; Chiu K; Shafrin J; Boskovic DH; Veeranki SP
    Digit Health; 2022; 8():20552076221084472. PubMed ID: 35295765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of a Digital Medicine System in Psychiatry.
    Rohatagi S; Profit D; Hatch A; Zhao C; Docherty JP; Peters-Strickland TS
    J Clin Psychiatry; 2016 Sep; 77(9):e1101-e1107. PubMed ID: 27487251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an Ingestible, Sensor-Based Digital Adherence System to Strengthen the Therapeutic Relationship in Serious Mental Illness.
    Richey AG; Kovacs I; Browne S
    JMIR Ment Health; 2022 Dec; 9(12):e39047. PubMed ID: 36459392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder.
    Kane JM; Perlis RH; DiCarlo LA; Au-Yeung K; Duong J; Petrides G
    J Clin Psychiatry; 2013 Jun; 74(6):e533-40. PubMed ID: 23842023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wirelessly Observed Therapy to Optimize Adherence and Target Interventions for Oral Hepatitis C Treatment: Observational Pilot Study.
    Bonacini M; Kim Y; Pitney C; McKoin L; Tran M; Landis C
    J Med Internet Res; 2020 Feb; 22(2):e15532. PubMed ID: 32352385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data.
    Yan T; Greene M; Chang E; Hartry A; Touya M; Broder MS
    Adv Ther; 2018 Oct; 35(10):1612-1625. PubMed ID: 30206822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human factors evaluation of a novel digital medicine system in psychiatry.
    Peters-Strickland T; Hatch A; Adenwala A; Atkinson K; Bartfeld B
    Neuropsychiatr Dis Treat; 2018; 14():553-565. PubMed ID: 29497299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants.
    Eisenberger U; Wüthrich RP; Bock A; Ambühl P; Steiger J; Intondi A; Kuranoff S; Maier T; Green D; DiCarlo L; Feutren G; De Geest S
    Transplantation; 2013 Aug; 96(3):245-50. PubMed ID: 23823651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial.
    Sajatovic M; Coconcea N; Ignacio RV; Blow FC; Hays RW; Cassidy KA; Meyer WJ
    J Clin Psychiatry; 2008 Jan; 69(1):41-6. PubMed ID: 18312036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a Digital Medicine System in Psychiatry: Ingestion Detection Rate and Latency Period.
    Profit D; Rohatagi S; Zhao C; Hatch A; Docherty JP; Peters-Strickland TS
    J Clin Psychiatry; 2016 Sep; 77(9):e1095-e1100. PubMed ID: 27379966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ingestible Sensors and Medication Adherence: Focus on Use in Serious Mental Illness.
    Alipour A; Gabrielson S; Patel PB
    Pharmacy (Basel); 2020 Jun; 8(2):. PubMed ID: 32560178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.